Skip to main content
Top
Published in: Diabetologia 2/2015

01-02-2015 | Article

Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study

Authors: Vasudha Ahuja, Takashi Kadowaki, Rhobert W. Evans, Aya Kadota, Tomonori Okamura, Samar R. El Khoudary, Akira Fujiyoshi, Emma J. M. Barinas-Mitchell, Takashi Hisamatsu, Abhishek Vishnu, Katsuyuki Miura, Hiroshi Maegawa, Aiman El-Saed, Atsunori Kashiwagi, Lewis H. Kuller, Hirotsugu Ueshima, Akira Sekikawa, for the ERA JUMP Study Group

Published in: Diabetologia | Issue 2/2015

Login to get access

Abstract

Aims/hypothesis

At the same level of BMI, white people have less visceral adipose tissue (VAT) and are less susceptible to developing type 2 diabetes than Japanese people. No previous population-based studies have compared insulin resistance and insulin secretion between these two races in a standardised manner that accounts for VAT. We compared HOMA-IR, HOMA of beta cell function (HOMA-β%) and disposition index (DI) in US white men and Japanese men in Japan.

Methods

We conducted a population-based, cross-sectional study, comprising 298 white men and 294 Japanese men aged 40–49 years without diabetes. Insulin, glucose, VAT and other measurements were performed at the University of Pittsburgh. We used ANCOVA to compare geometric means of HOMA-IR, HOMA-β% and DI, adjusting for VAT and other covariates.

Results

White men had higher HOMA-IR, HOMA-β% and DI than Japanese men, and the difference remained significant (p < 0.01) after adjusting for VAT (geometric mean [95% CI]): 3.1 (2.9, 3.2) vs 2.5 (2.4, 2.6), 130.8 (124.6, 137.3) vs 86.7 (82.5, 91.0), and 42.4 (41.0, 44.0) vs 34.8 (33.6, 36.0), respectively. Moreover, HOMA-IR, HOMA-β% and DI were significantly higher in white men even after further adjustment for BMI, impaired fasting glucose and other risk factors.

Conclusions/interpretation

The higher VAT-adjusted DI in white men than Japanese men may partly explain lower susceptibility of white people than Japanese people to developing type 2 diabetes. The results, however, should be interpreted with caution because the assessment of insulin indices was made using fasting samples and adjustment was not made for baseline glucose tolerance. Further studies using formal methods to evaluate insulin indices are warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huxley R, James WP, Barzi F et al (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev Off J Int Assoc Study Obes 9(Suppl 1):53–61CrossRef Huxley R, James WP, Barzi F et al (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev Off J Int Assoc Study Obes 9(Suppl 1):53–61CrossRef
2.
go back to reference Kadowaki T, Sekikawa A, Murata K et al (2006) Japanese men have larger areas of visceral adipose tissue than White men in the same levels of waist circumference in a population-based study. Int J Obes 30:1163–1165CrossRef Kadowaki T, Sekikawa A, Murata K et al (2006) Japanese men have larger areas of visceral adipose tissue than White men in the same levels of waist circumference in a population-based study. Int J Obes 30:1163–1165CrossRef
3.
go back to reference Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359–404PubMedCrossRef Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359–404PubMedCrossRef
4.
go back to reference Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51:2170–2178PubMedCrossRef Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51:2170–2178PubMedCrossRef
5.
go back to reference Torrens JI, Skurnick J, Davidow AL et al (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef Torrens JI, Skurnick J, Davidow AL et al (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef
6.
go back to reference Chiu KC, Cohan P, Lee NP, Chuang LM (2000) Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23:1353–1358PubMedCrossRef Chiu KC, Cohan P, Lee NP, Chuang LM (2000) Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23:1353–1358PubMedCrossRef
7.
go back to reference Moller JB, Pedersen M, Tanaka H et al (2014) Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Whites. Diabetes Care 37:796–804PubMedCrossRef Moller JB, Pedersen M, Tanaka H et al (2014) Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Whites. Diabetes Care 37:796–804PubMedCrossRef
8.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef
9.
go back to reference Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ (2013) Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 36:1789–1796PubMedCentralPubMedCrossRef Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ (2013) Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 36:1789–1796PubMedCentralPubMedCrossRef
10.
go back to reference Sekikawa A, Ueshima H, Kadowaki T et al (2007) Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 165:617–624PubMedCentralPubMedCrossRef Sekikawa A, Ueshima H, Kadowaki T et al (2007) Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 165:617–624PubMedCentralPubMedCrossRef
11.
go back to reference ADA (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(Suppl 1):S11–S66 ADA (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(Suppl 1):S11–S66
12.
go back to reference Howard G, Bergman R, Wagenknecht LE et al (1998) Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol 8:358–369PubMedCrossRef Howard G, Bergman R, Wagenknecht LE et al (1998) Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol 8:358–369PubMedCrossRef
13.
go back to reference Lee S, Janssen I, Ross R (2004) Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol 97:948–954PubMedCrossRef Lee S, Janssen I, Ross R (2004) Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol 97:948–954PubMedCrossRef
14.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
15.
go back to reference Matsuda M (2010) Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis 20:79–86PubMedCrossRef Matsuda M (2010) Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis 20:79–86PubMedCrossRef
16.
go back to reference Steinbrecher A, Morimoto Y, Heak S et al (2011) The preventable proportion of type 2 diabetes by ethnicity: the multiethnic cohort. Ann Epidemiol 21:526–535PubMedCentralPubMedCrossRef Steinbrecher A, Morimoto Y, Heak S et al (2011) The preventable proportion of type 2 diabetes by ethnicity: the multiethnic cohort. Ann Epidemiol 21:526–535PubMedCentralPubMedCrossRef
17.
go back to reference Zafrir B, Jain M (2014) Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovasc Drugs Ther 28:361–377PubMedCrossRef Zafrir B, Jain M (2014) Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovasc Drugs Ther 28:361–377PubMedCrossRef
18.
go back to reference Meng YX, Ford ES, Li C et al (2007) Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clin Chem 53:2152–2159PubMedCrossRef Meng YX, Ford ES, Li C et al (2007) Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clin Chem 53:2152–2159PubMedCrossRef
19.
go back to reference Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935PubMedCrossRef Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935PubMedCrossRef
20.
go back to reference Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diabetes Rep 9:193–199CrossRef Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diabetes Rep 9:193–199CrossRef
21.
go back to reference Fu D, Cong X, Ma Y et al (2013) Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects. PLoS One 8:e55727PubMedCentralPubMedCrossRef Fu D, Cong X, Ma Y et al (2013) Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects. PLoS One 8:e55727PubMedCentralPubMedCrossRef
22.
go back to reference Reaven GM (2011) Insulin resistance: the link between obesity and cardiovascular disease. Med Clin N Am 95:875–892PubMedCrossRef Reaven GM (2011) Insulin resistance: the link between obesity and cardiovascular disease. Med Clin N Am 95:875–892PubMedCrossRef
23.
go back to reference Fujimoto WY, Leonetti DL, Kinyoun JL et al (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721–729PubMedCrossRef Fujimoto WY, Leonetti DL, Kinyoun JL et al (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721–729PubMedCrossRef
24.
go back to reference Nakanishi S, Okubo M, Yoneda M, Jitsuiki K, Yamane K, Kohno N (2004) A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother 58:571–577PubMedCrossRef Nakanishi S, Okubo M, Yoneda M, Jitsuiki K, Yamane K, Kohno N (2004) A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother 58:571–577PubMedCrossRef
25.
go back to reference Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Watanabe S (2013) Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. J Diabetes Investig 4:274–280PubMedCentralPubMedCrossRef Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Watanabe S (2013) Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. J Diabetes Investig 4:274–280PubMedCentralPubMedCrossRef
26.
go back to reference DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270–1287PubMedCentralPubMedCrossRef DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270–1287PubMedCentralPubMedCrossRef
27.
go back to reference Lee ET, Keen H, Bennett PH, Fuller JH, Lu M (2001) Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 44(Suppl 2):S3–S13PubMedCrossRef Lee ET, Keen H, Bennett PH, Fuller JH, Lu M (2001) Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 44(Suppl 2):S3–S13PubMedCrossRef
28.
go back to reference Yokoyama H, Matsushima M, Kawai K et al (2011) Low incidence of cardiovascular events in Japanese patients with type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabet Med 28:1221–1228PubMedCrossRef Yokoyama H, Matsushima M, Kawai K et al (2011) Low incidence of cardiovascular events in Japanese patients with type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabet Med 28:1221–1228PubMedCrossRef
29.
go back to reference Kim SH, Abbasi F, Reaven GM (2004) Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27:1998–2002PubMedCrossRef Kim SH, Abbasi F, Reaven GM (2004) Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27:1998–2002PubMedCrossRef
30.
go back to reference Boyko EJ, Jensen CC (2007) Do we know what homeostasis model assessment measures? If not, does it matter? Diabetes Care 30:2725–2728PubMedCrossRef Boyko EJ, Jensen CC (2007) Do we know what homeostasis model assessment measures? If not, does it matter? Diabetes Care 30:2725–2728PubMedCrossRef
31.
go back to reference Festa A, Haffner SM, Wagenknecht LE, Lorenzo C, Hanley AJ (2013) Longitudinal decline of beta-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 98:4152–4159PubMedCentralPubMedCrossRef Festa A, Haffner SM, Wagenknecht LE, Lorenzo C, Hanley AJ (2013) Longitudinal decline of beta-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 98:4152–4159PubMedCentralPubMedCrossRef
32.
go back to reference Song Y, Manson JE, Tinker L et al (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care 30:1747–1752PubMedCentralPubMedCrossRef Song Y, Manson JE, Tinker L et al (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care 30:1747–1752PubMedCentralPubMedCrossRef
33.
go back to reference Ning F, Qiao Q, Tuomilehto J et al (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26:245–253PubMedCrossRef Ning F, Qiao Q, Tuomilehto J et al (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26:245–253PubMedCrossRef
34.
go back to reference Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087–1092PubMedCrossRef Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087–1092PubMedCrossRef
35.
go back to reference Mari A, Ahren B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529–533PubMedCrossRef Mari A, Ahren B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529–533PubMedCrossRef
36.
go back to reference Guglielmi C, Palermo A, Pozzilli P (2012) Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev 28(Suppl 2):40–46PubMedCrossRef Guglielmi C, Palermo A, Pozzilli P (2012) Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev 28(Suppl 2):40–46PubMedCrossRef
37.
go back to reference Takeda H, Kawasaki E, Shimizu I et al (2002) Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25:995–1001PubMedCrossRef Takeda H, Kawasaki E, Shimizu I et al (2002) Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25:995–1001PubMedCrossRef
Metadata
Title
Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study
Authors
Vasudha Ahuja
Takashi Kadowaki
Rhobert W. Evans
Aya Kadota
Tomonori Okamura
Samar R. El Khoudary
Akira Fujiyoshi
Emma J. M. Barinas-Mitchell
Takashi Hisamatsu
Abhishek Vishnu
Katsuyuki Miura
Hiroshi Maegawa
Aiman El-Saed
Atsunori Kashiwagi
Lewis H. Kuller
Hirotsugu Ueshima
Akira Sekikawa
for the ERA JUMP Study Group
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3414-6

Other articles of this Issue 2/2015

Diabetologia 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine